Centogene Statements
39
Data from Centogene`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency :
EUR - Euro
Last reporting period :
31 Dec, 2023
New report :
04 Sep, 2024
Reporting period :
Semi-annual
Earnings release date:
—
Expected release date:
—
Centogene Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
48.536
97.1 %
100
30.841
63.5
17.695
88.4 %
36.5
12.361
25.5
45.152
93
46.096
55.5 %
95
-28.401
-40.2 %
-58.5
-5.427
-11.2
-0.159
-0.3
-35.245
-44.2 %
-72.6
0.287
0.6
-35.532
-45.3 %
-73.2
-1.262
28.163
24.624
-48.1 %
100
15.232
61.9
9.392
-52.8 %
38.1
6.851
27.8
23.871
96.9
29.653
-47.5 %
120.4
-20.261
44.7 %
-82.3
-2.748
-11.2
-0.442
-1.8
-24.443
36.7 %
-99.3
0.013
0.05
-24.456
23.2 %
-99.3
-0.878
27.866
47.473
323.9 %
100
27.554
58
19.919
332.1 %
42
17.488
36.8
42.079
88.6
56.534
266.2 %
119.1
-36.615
-237.8 %
-77.1
-4.397
-9.3
2.574
5.4
-38.596
-229.6 %
-81.3
0.107
0.2
-31.841
-207.6 %
-67.07
-1.18
26.811
11.2
9.9 %
100
6.59
58.8
4.61
23.3 %
41.2
4.46
39.8
11.14
99.5
15.44
8 %
137.9
-10.84
-2.7 %
-96.8
-2.28
-20.4
1.4
12.5
-11.71
-4.7 %
-104.6
0.18
1.6
-10.35
-57.3 %
-92.4
-0.38
27.23
10.19
246.4 %
100
6.45
63.3
3.74
-72.9 %
36.7
4.61
45.2
10.42
102.3
14.3
-34.7 %
140.3
-10.56
-30.7 %
-103.6
-0.86
-8.4
0.24
2.4
-11.18
-36.7 %
-109.7
—
0
-6.58
41.1 %
-64.6
-0.24
26.84
-6.96
-123 %
100
-20.78
298.6
13.81
354.8 %
-198.4
7.09
-101.9
13.6
-195.4
21.89
42 %
-314.5
-8.08
61.2 %
116.1
-0.1
1.4
—
0
-8.18
62.1 %
117.5
-0.23
3.3
-11.18
48.3 %
160.6
-0.47
23.53
30.2
227.9 %
100
35.62
117.9
-5.42
-309.3 %
-17.9
3.82
12.6
12.61
41.8
15.42
-2.2 %
51.1
-20.85
-58.3 %
-69.04
-0.26
-0.9
—
0
-21.61
-62 %
-71.6
0.04
0.1
-21.64
-158.9 %
-71.7
-0.96
22.55
9.21
-5.9 %
100
6.62
71.9
2.59
-27.9 %
28.1
4.05
44
12.98
140.9
15.76
-10.6 %
171.1
-13.17
6.1 %
-143
-0.18
-2
—
0
-13.34
6.6 %
-144.8
0.12
1.3
-8.36
-64.9 %
-90.8
-0.38
21.99
9.79
149.7 %
100
6.21
63.4
3.59
123.8 %
36.7
4.34
44.3
13.62
139.1
17.62
-10.1 %
180
-14.03
59.5 %
-143.3
-0.26
-2.7
—
0
-14.29
59.5 %
-146
—
0
-5.07
-284.4 %
-51.8
-0.22
22.18
-19.68
-154.2 %
100
-4.61
23.4
-15.07
-247 %
76.6
5.35
-27.2
16.5
-83.8
19.61
41.9 %
-99.6
-34.67
-871.1 %
176.2
0.17
-0.9
—
0
-35.31
-537.4 %
179.4
-0.01
0.05
2.75
148.8 %
-14
0.12
22.51
36.31
273.6 %
100
26.06
71.8
10.25
253.4 %
28.2
4.8
13.2
9.67
26.6
13.82
10.9 %
38.1
-3.57
62.7 %
-9.8
-0.81
-2.2
—
0
-5.54
46.5 %
-15.3
0.1
0.3
-5.64
45.6 %
-15.5
-0.26
21.86
9.72
-19.7 %
100
6.82
70.2
2.9
-43 %
29.8
2.49
25.6
9.44
97.1
12.46
3.2 %
128.2
-9.56
-36.8 %
-98.4
-0.3
-3.09
—
0
-10.36
-20.3 %
-106.6
—
0
-10.36
-18.5 %
-106.6
-0.52
19.86
12.11
-20.4 %
100
7.02
58
5.09
-41.6 %
42
2.3
19
9.64
79.6
12.07
-9.8 %
99.7
-6.99
-49.7 %
-57.7
-0.45
-3.7
—
0
-8.61
-71.5 %
-71.1
0.13
1.1
-8.74
-74.1 %
-72.2
-0.44
19.86
15.22
30.8 %
100
6.51
42.8
8.72
74.4 %
57.3
3.47
22.8
9.78
64.3
13.38
59.9 %
87.9
-4.67
-38.6 %
-30.7
-0.35
-2.3
—
0
-5.02
-17.3 %
-33
-0.01
-0.07
-5.02
-17.3 %
-33
-0.25
19.86
11.64
3.8 %
100
6.64
57
5
-1.8 %
43
2.01
17.3
6.67
57.3
8.37
-16.1 %
71.9
-3.37
31.1 %
-29
-1.43
-12.3
—
0
-4.28
32 %
-36.8
—
0
-4.28
31.8 %
-36.8
-0.22
19.86
11.21
11.1 %
100
6.11
54.5
5.09
-12.8 %
45.4
2.41
21.5
8.04
71.7
9.98
8.5 %
89
-4.89
-46 %
-43.6
-0.21
-1.9
—
0
-6.29
-77.7 %
-56.1
-0.01
-0.09
-6.28
-79.9 %
-56.02
-0.32
19.86
10.09
-24.6 %
100
4.24
42
5.84
-14.2 %
57.9
2.52
25
6.92
68.6
9.2
15.9 %
91.2
-3.35
-196.5 %
-33.2
-0.19
-1.9
—
0
-3.54
-156.5 %
-35.08
-0.05
-0.5
-3.49
-183.7 %
-34.6
-0.18
19.86
13.38
—
100
6.57
49.1
6.81
—
50.9
1.43
10.7
7.28
54.4
7.94
—
59.3
-1.13
—
-8.4
-0.25
-1.9
—
0
-1.38
—
-10.3
-0.15
-1.1
-1.23
—
-9.2
-0.06
19.86